- Home
- VITL vs CERT Comparison
VITL vs CERT Comparison
Compare VITL & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VITL
- CERT
- Stock Information
- Founded
- VITL 2007
- CERT 2008
- Country
- VITL United States
- CERT United States
- Employees
- VITL N/A
- CERT N/A
- Industry
- VITL Packaged Foods
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- VITL Consumer Staples
- CERT Technology
- Exchange
- VITL Nasdaq
- CERT Nasdaq
- Market Cap
- VITL 1.6B
- CERT 1.7B
- IPO Year
- VITL 2020
- CERT 2020
- Fundamental
- Price
- VITL $39.54
- CERT $11.49
- Analyst Decision
- VITL Strong Buy
- CERT Buy
- Analyst Count
- VITL 8
- CERT 6
- Target Price
- VITL $43.88
- CERT $15.60
- AVG Volume (30 Days)
- VITL 828.7K
- CERT 2.0M
- Earning Date
- VITL 08-07-2025
- CERT 08-05-2025
- Dividend Yield
- VITL N/A
- CERT N/A
- EPS Growth
- VITL 30.46
- CERT N/A
- EPS
- VITL 1.13
- CERT N/A
- Revenue
- VITL $620,567,000.00
- CERT $394,498,000.00
- Revenue This Year
- VITL $25.26
- CERT $11.57
- Revenue Next Year
- VITL $19.41
- CERT $8.93
- P/E Ratio
- VITL $35.15
- CERT N/A
- Revenue Growth
- VITL 23.96
- CERT 9.37
- 52 Week Low
- VITL $27.91
- CERT $8.64
- 52 Week High
- VITL $46.58
- CERT $16.93
- Technical
- Relative Strength Index (RSI)
- VITL 74.69
- CERT 52.30
- Support Level
- VITL $35.30
- CERT $10.23
- Resistance Level
- VITL $39.66
- CERT $11.98
- Average True Range (ATR)
- VITL 1.58
- CERT 0.50
- MACD
- VITL 0.61
- CERT 0.11
- Stochastic Oscillator
- VITL 98.62
- CERT 69.97
About VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.